Prospective interest of molecular neuroimaging in Alzheimer's disease.
This article presents the prospects of molecular imaging in Alzheimer's Disease (AD), regarding instrumentation, imaging agents, and image processing, and their possible impact on AD research and clinical care.
CERIMED, Aix-Marseille University, 27, boulevard Jean-Moulin, 13385 Marseille cedex 05, France. eric.guedj@ap-hm.fr
E
E
Guedj
D000368:Aged; D000544:Alzheimer Disease / Q000175:diagnosis* / Q000000981:diagnostic imaging; D015415:Biomarkers / Q000378:metabolism; D050483:Dopamine Plasma Membrane Transport Proteins / Q000378:metabolism; D006801:Humans; D007091:Image Processing, Computer-Assisted; D008279:Magnetic Resonance Imaging; D025202:Molecular Diagnostic Techniques / Q000379:methods*; D059906:Neuroimaging / Q000379:methods*; D049268:Positron-Emission Tomography; D015899:Tomography, Emission-Computed, Single-Photon; D014057:Tomography, X-Ray Computed
D015415:Biomarkers; D050483:Dopamine Plasma Membrane Transport Proteins